 Replimune Group NASDAQ:REPL and PDL BioPharma NASDAQ:PDLI are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, analyst recommendations, risk, profitability and earnings. Insider Institutional Ownership 60.1 of Replimune Group shares are owned by institutional investors. Comparatively, ... 